Literature DB >> 2756910

Inhibitory effect of high caloric load of carbohydrates or lipids on human pancreatic secretions: a jejunal brake.

N Vidon1, S Chaussade, F Merite, B Huchet, C Franchisseur, J J Bernier.   

Abstract

Effects of jejunal infusion of a saline solution, a protein meal, and a mixed protein and carbohydrate meal on biliopancreatic secretions were compared in six healthy volunteers. Protein infusion stimulated biliopancreatic secretions whereas carbohydrate infusion inhibited these secretions compared with saline infusion. The roles of lipid, carbohydrate, and caloric load on the inhibition of pancreatic secretions by jejunal infusion of nutrients was investigated in six other healthy volunteers. Carbohydrate, lipid, and the mixed meal inhibited pancreatic secretions whereas the carbohydrate solution was the only one that inhibited biliary secretion. These studies indicate that the mechanism of jejunal brake seems mainly related to the jejunal caloric load. In malabsorption or in the short bowel syndrome, a high caloric load or unabsorbed nutrients in the jejunum further inhibits pancreatic secretion, contributing to the loss of nutrients from the intestinal tract.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2756910     DOI: 10.1093/ajcn/50.2.231

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  3 in total

1.  Jejunal brake.

Authors:  N Vidon; J J Bernier; A Pfeiffer; P Sogni; S Chaussade
Journal:  Dig Dis Sci       Date:  1996-12       Impact factor: 3.199

2.  Stimulated gastrointestinal hormone release and gallbladder contraction during continuous jejunal feeding in patients with pancreatic pseudocyst is inhibited by octreotide.

Authors:  T Takács; F Hajnal; J Németh; J Lonovics; A Pap
Journal:  Int J Pancreatol       Date:  2000-12

Review 3.  Effect of diet and individual dietary guidance on gastrointestinal endocrine cells in patients with irritable bowel syndrome (Review).

Authors:  Tarek Mazzawi; Magdy El-Salhy
Journal:  Int J Mol Med       Date:  2017-08-11       Impact factor: 4.101

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.